<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
                    <title>Phys.org news tagged with:biotechnology company</title>
            <link>https://phys.org/</link>
            <language>en-us</language>
            <description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

                            <item>
                    <title>A framework for the discovery of cell state-correcting medicines</title>
                    <description>Cellarity, a biotechnology company developing cell state-correcting therapies through integrated multi-omics and AI modeling, reports the publication of a manuscript in the journal Science, which articulates a framework for the integration of advanced transcriptomic datasets and AI models to improve drug discovery.</description>
                    <link>https://phys.org/news/2025-10-framework-discovery-cell-state-medicines.html</link>
                    <category>Cell &amp; Microbiology</category>                    <pubDate>Thu, 23 Oct 2025 14:00:08 EDT</pubDate>
                    <guid isPermaLink="false">news680341333</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/cell-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Researchers advance technology for protecting engineered cells</title>
                    <description>Genetically engineered cell lines used in biomedical research have long been prone to misidentification and unauthorized use, wasting billions of dollars each year and jeopardizing critical scientific discoveries. These problems not only undermine reproducibility of research results, but also put valuable intellectual property at risk.</description>
                    <link>https://phys.org/news/2025-09-advance-technology-cells.html</link>
                    <category>Cell &amp; Microbiology</category>                    <pubDate>Wed, 03 Sep 2025 11:52:04 EDT</pubDate>
                    <guid isPermaLink="false">news676119122</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/researchers-advance-te.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Return of the huia? Why Māori worldviews must be part of the &#039;de-extinction&#039; debate</title>
                    <description>The recent announcement of the resurrection of the dire wolf generated considerable global media attention and widespread scientific criticism.</description>
                    <link>https://phys.org/news/2025-05-huia-mori-worldviews-de-extinction.html</link>
                    <category>Plants &amp; Animals</category>                    <pubDate>Thu, 15 May 2025 09:15:05 EDT</pubDate>
                    <guid isPermaLink="false">news666519302</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/return-of-the-huia-why.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How local regulations helped create certainty and safety principles that enabled biotech&#039;s massive growth</title>
                    <description>It&#039;s considered a scientific landmark: A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA, ensuring that researchers would apply caution to gene splicing. Those ideas have been so useful that in the decades since, when new topics in scientific safety arise, there are still calls for Asilomar-type conferences to craft good ground rules.</description>
                    <link>https://phys.org/news/2025-04-local-certainty-safety-principles-enabled.html</link>
                    <category>Biotechnology</category>                    <pubDate>Wed, 16 Apr 2025 10:04:05 EDT</pubDate>
                    <guid isPermaLink="false">news664016641</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/how-local-regulations.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Scientists say they &#039;de-extincted&#039; dire wolves: Experts are skeptical</title>
                    <description>When news broke that scientists in Texas had successfully reintroduced the long-extinct dire wolf to the modern world, more people than just &quot;Game of Thrones&quot; fans took notice.</description>
                    <link>https://phys.org/news/2025-04-scientists-de-extincted-dire-wolves.html</link>
                    <category>Biotechnology</category>                    <pubDate>Mon, 14 Apr 2025 14:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news663843078</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/scientists-say-they-de.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Improved lipid-polymer nanoparticle could advance inhalable mRNA medications and vaccines</title>
                    <description>Most people don&#039;t enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled.</description>
                    <link>https://phys.org/news/2024-11-lipid-polymer-nanoparticle-advance-inhalable.html</link>
                    <category>Bio &amp; Medicine</category>                    <pubDate>Wed, 13 Nov 2024 11:34:03 EST</pubDate>
                    <guid isPermaLink="false">news650720041</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/nasal-spray.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Businesses trying to come clean about their impact on nature can end up concealing more than they reveal</title>
                    <description>Humans have overfished the ocean, cleared forests, polluted water and created a climate crisis by burning fossil fuels. These actions are affecting biodiversity around the world, from remote islands to our own backyards.</description>
                    <link>https://phys.org/news/2024-09-businesses-impact-nature-concealing-reveal.html</link>
                    <category>Economics &amp; Business</category>                    <pubDate>Mon, 23 Sep 2024 13:30:01 EDT</pubDate>
                    <guid isPermaLink="false">news646314885</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2020/greenbusiness.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Fermentation revolution? Trash becomes treasure as bio-waste yields valuable acetone and isopropanol</title>
                    <description>In a major stride towards sustainable industrial fermentation, a team of researchers at Delft University of Technology (TU Delft) in The Netherlands, has unveiled pioneering advancements in the purification of isopropanol and acetone from the fermentation of waste gases. The study, published in the Journal of Chemical Technology and Biotechnology, introduces novel processes that promise to elevate the efficiency and viability of large-scale production.</description>
                    <link>https://phys.org/news/2024-01-fermentation-revolution-trash-treasure-bio.html</link>
                    <category>Biotechnology</category>                    <pubDate>Wed, 31 Jan 2024 17:00:03 EST</pubDate>
                    <guid isPermaLink="false">news625942801</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/fermentation-revolutio.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Study discovers how a system of proteins helps Salmonella survive inside macrophages</title>
                    <description>Salmonella is notorious for surviving and replicating in macrophages, which are normally lethal to invading bacteria because of their inhospitable environment. In a new study, researchers have discovered how a system of proteins, called TamAB, helps Salmonella survive under the harsh conditions inside macrophages.</description>
                    <link>https://phys.org/news/2024-01-proteins-salmonella-survive-macrophages.html</link>
                    <category>Cell &amp; Microbiology</category>                    <pubDate>Thu, 11 Jan 2024 15:40:03 EST</pubDate>
                    <guid isPermaLink="false">news624210001</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/new-insights-into-what.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>A synthetic biology platform enabling control over aging-associated stress response</title>
                    <description>Integrated Biosciences, a biotechnology company combining synthetic biology and machine learning to target aging, in collaboration with researchers at the University of California Santa Barbara, today announced a drug discovery platform that enables precise control of the integrated stress response (ISR), a biological pathway that is activated by cells in response to a wide variety of pathological and aging-associated conditions.</description>
                    <link>https://phys.org/news/2023-07-synthetic-biology-platform-enabling-aging-associated.html</link>
                    <category>Cell &amp; Microbiology</category>                    <pubDate>Wed, 19 Jul 2023 11:59:57 EDT</pubDate>
                    <guid isPermaLink="false">news608986793</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/integrated-biosciences.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Academic institutions receive lower financial returns from biotechnology licenses than commercial firms</title>
                    <description>The financial terms of biotechnology licenses from academic institutions are significantly less favorable than those of comparable licenses between commercial firms according to a new study from Bentley University&#039;s Center for Integration of Science and Industry. The study, published in the journal PLOS ONE, shows that the royalties and payments to academic institutions are significantly lower than those to commercial firms for similar licenses and products at the same stages of development.</description>
                    <link>https://phys.org/news/2023-03-academic-financial-biotechnology-commercial-firms.html</link>
                    <category>Biotechnology</category>                    <pubDate>Fri, 31 Mar 2023 14:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news599469668</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/paying-royalties.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Can we ethically justify harming animals for research? There are several schools of thought</title>
                    <description>Neuralink, the biotechnology company co-founded by Elon Musk, has been accused of animal cruelty and is under federal investigation in the United States for potential animal welfare violations.</description>
                    <link>https://phys.org/news/2022-12-ethically-animals-schools-thought.html</link>
                    <category>Plants &amp; Animals</category>                    <pubDate>Tue, 20 Dec 2022 13:11:03 EST</pubDate>
                    <guid isPermaLink="false">news590764261</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/can-we-ethically-justi.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Researchers identify the high-efficiency hacks cannabis cells use to make cannabinoids</title>
                    <description>For the first time, plant biologists have defined the high-efficiency &quot;hacks&quot; that cannabis cells use to make cannabinoids (THC/CBD). Although many biotechnology companies are currently trying to engineer THC/CBD outside the plant in yeast or cell cultures, it is largely unknown how the plant does it naturally.</description>
                    <link>https://phys.org/news/2022-08-high-efficiency-hacks-cannabis-cells-cannabinoids.html</link>
                    <category>Cell &amp; Microbiology</category>                    <pubDate>Tue, 02 Aug 2022 13:02:29 EDT</pubDate>
                    <guid isPermaLink="false">news578664144</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/cannabis.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Researchers develop unique 3D printed system for harvesting stem cells from bioreactors</title>
                    <description>Researchers have developed a unique 3D printed system for harvesting stem cells from bioreactors, offering the potential for high quality, wide-scale production of stem cells in Australia at a lower cost.</description>
                    <link>https://phys.org/news/2022-06-unique-3d-harvesting-stem-cells.html</link>
                    <category>Biotechnology</category>                    <pubDate>Thu, 16 Jun 2022 04:14:21 EDT</pubDate>
                    <guid isPermaLink="false">news574571657</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/new-solution-for-stem.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Genetically modified corn found to not damage non-target organisms</title>
                    <description>The largest, highest quality analysis of data ever conducted reveals that genetically modified Bt corn has little impact on nontarget insects and other organisms, especially compared to growing conventional corn. This study was published today in Environmental Evidence by a USDA Agricultural Research Service scientist and his Swiss colleagues.</description>
                    <link>https://phys.org/news/2022-06-genetically-corn-non-target.html</link>
                    <category>Ecology</category>                    <pubDate>Mon, 06 Jun 2022 13:46:39 EDT</pubDate>
                    <guid isPermaLink="false">news573741996</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/genetically-modified-c.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Investment risk and return from emerging public biotech companies comparable to non-biotech</title>
                    <description>Investing in biotech companies may not entail higher risk than investing in other sectors, according to a new report from Bentley University&#039;s Center for Integration of Science and Industry. A large scale study of biotechnology companies that completed Initial Public Offerings (IPOs) from 1997-2016 demonstrates that these companies produced more than $100 billion in shareholder value and almost $100 billion in new value creation despite a failure rate greater than 50%. The study compared the financial performance and economic value created by these biotech companies to non-biotechnology controls that had similarly timed IPOs.</description>
                    <link>https://phys.org/news/2021-01-investment-emerging-biotech-companies-non-biotech.html</link>
                    <category>Economics &amp; Business</category>                    <pubDate>Wed, 06 Jan 2021 14:00:06 EST</pubDate>
                    <guid isPermaLink="false">news529138072</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2021/biotech.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Producing milk from yeast that looks and tastes like cow&#039;s milk</title>
                    <description>Might a new technological development of researchers from Tel Aviv University soon revolutionize the dairy products we consume? The initiators of the development believe that in the not-too-distant future we will be able to buy dairy products in the supermarket that are identical in taste and color to the ordinary dairy products that we consume today, but with one small difference: the dairy products will be produced from yeast rather than from cow.</description>
                    <link>https://phys.org/news/2021-01-yeast-cow.html</link>
                    <category>Cell &amp; Microbiology</category>                    <pubDate>Wed, 06 Jan 2021 11:08:36 EST</pubDate>
                    <guid isPermaLink="false">news529153712</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2021/producingmil.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Chemical engineers develop biosecurity tool to detect genetically engineered organisms in the wild</title>
                    <description>If a genetically or synthetically engineered organism is released into the environment, how will we know? How can we tell it apart from the millions of microorganisms that exist naturally in the wild? That&#039;s the challenge being taken on by a multi-institution research team, including Eric Young, assistant professor of chemical engineering at Worcester Polytechnic Institute (WPI), that is developing a biosecurity tool that can detect engineered microorganisms based on their unique DNA signatures.</description>
                    <link>https://phys.org/news/2019-05-chemical-biosecurity-tool-genetically-wild.html</link>
                    <category>Biotechnology</category>                    <pubDate>Tue, 21 May 2019 16:04:46 EDT</pubDate>
                    <guid isPermaLink="false">news477673476</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2019/developingbi.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Tapping our microbiomes for new health treatments</title>
                    <description>Fecal transplants for treating gut diseases were the first reported therapies based on the idea that the human microbiome is inextricably linked to our health. Now, as researchers further flesh out this connection, dozens of biotechnology and pharmaceutical companies are moving ahead and investigating new therapeutic directions, according to the cover story of Chemical &amp; Engineering News (C&amp;EN), the weekly newsmagazine of the American Chemical Society.</description>
                    <link>https://phys.org/news/2015-09-microbiomes-health-treatments.html</link>
                    <category>Other</category>                    <pubDate>Wed, 30 Sep 2015 09:32:59 EDT</pubDate>
                    <guid isPermaLink="false">news362824367</guid>
                                    </item>
                            <item>
                    <title>Google promises new thinking for health company</title>
                    <description>Google announced Wednesday it was launching a new company focused on health and well-being, and hinted at cooperation with longtime rival Apple in the venture.</description>
                    <link>https://phys.org/news/2013-09-google-health-company-calico.html</link>
                    <category>Business</category>                    <pubDate>Wed, 18 Sep 2013 13:28:07 EDT</pubDate>
                    <guid isPermaLink="false">news298729674</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2013/1-larrypagegoo.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>World Food Prize goes to 3 biotech scientists</title>
                    <description>This year&#039;s World Food Prize is going to a Belgian scientist and two researchers in the United States for their innovations that brought the world genetically modified crops.</description>
                    <link>https://phys.org/news/2013-06-world-food-prize-biotech-scientists.html</link>
                    <category>Biotechnology</category>                    <pubDate>Wed, 19 Jun 2013 15:10:05 EDT</pubDate>
                    <guid isPermaLink="false">news290872253</guid>
                                    </item>
                            <item>
                    <title>US court to decide if human genes can be patented</title>
                    <description>The Supreme Court announced Friday it will decide whether companies can patent human genes, a decision that could reshape medical research in the United States and the fight against diseases like breast and ovarian cancer.</description>
                    <link>https://phys.org/news/2012-11-court-companies-patent-genes.html</link>
                    <category>Biotechnology</category>                    <pubDate>Fri, 30 Nov 2012 18:44:03 EST</pubDate>
                    <guid isPermaLink="false">news273523412</guid>
                                    </item>
                            <item>
                    <title>Soft ray looks to save lives by developing rapid, low-cost system for detection of bacteria in blood platelets</title>
                    <description>Paul E. Johnson envisions the day when most citizens can have their blood platelets checked quickly for bacteria at a low cost. And he has created the technology that he believes can make a difference in eventually saving lives.</description>
                    <link>https://phys.org/news/2012-03-soft-ray-rapid-low-cost-bacteria.html</link>
                    <category>Biochemistry</category>                    <pubDate>Fri, 16 Mar 2012 08:06:32 EDT</pubDate>
                    <guid isPermaLink="false">news251103962</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2012/softraylooks.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Durham University spin-out company scoops an &#039;Oscar for innovation&#039;</title>
                    <description>Reinnervate, an innovative biotechnology company founded by Professor Stefan Przyborski of Durham University&#039;s School of Biological and Biomedical Sciences, has won a major international research and development award at the prestigious Annual R&amp;D 100 Awards.</description>
                    <link>https://phys.org/news/2011-10-durham-university-spin-out-company-scoops.html</link>
                    <category>Engineering</category>                    <pubDate>Wed, 19 Oct 2011 09:56:31 EDT</pubDate>
                    <guid isPermaLink="false">news238236964</guid>
                                    </item>
                            <item>
                    <title>Sanofi-Aventis to buy Genzyme for $20.1 bln cash</title>
                    <description>(AP) --  French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash $20.1 billion deal that ends months of corporate haggling and positions Sanofi at the forefront of the market in lucrative drugs for rare genetic disorders.</description>
                    <link>https://phys.org/news/2011-02-sanofi-aventis-genzyme-201b.html</link>
                    <category>Biotechnology</category>                    <pubDate>Wed, 16 Feb 2011 04:09:22 EST</pubDate>
                    <guid isPermaLink="false">news217051742</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/sanofiaventi.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Cloned beef traced to Wisconsin cow</title>
                    <description>Mark Rueth&#039;s Holstein cow Paradise had just been crowned supreme champion of the World Dairy Expo in Madison, Wis., in 2000 when a biotechnology company salesman approached him ringside and offered a cut-rate deal to clone Paradise so she could &quot;live forever,&quot; and make his farm more profitable.</description>
                    <link>https://phys.org/news/2010-08-cloned-beef-wisconsin-cow.html</link>
                    <category>Biotechnology</category>                    <pubDate>Tue, 17 Aug 2010 20:10:01 EDT</pubDate>
                    <guid isPermaLink="false">news201283328</guid>
                                    </item>
                        </channel>
</rss>